![HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1% CREAM [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/8838d911-0db2-f66e-e053-2995a90acb53/-2 end.jpg)
![HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1% CREAM [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/8838d911-0db2-f66e-e053-2995a90acb53/2094-2 front.jpg)
![HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1% CREAM [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/8838d911-0db2-f66e-e053-2995a90acb53/2094-2 middle.jpg)
- Directions for use
- SIncerus Florida, LLC. Adverse reactions
- Active, inactive
- HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%. Cream 30 gm
-
INGREDIENTS AND APPEARANCE
HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%
hyaluronic acid sodium salt 0.5% / tazarotene 0.1% creamProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-2094 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM 0.5 g in 100 g TAZAROTENE (UNII: 81BDR9Y8PS) (TAZAROTENE - UNII:81BDR9Y8PS) TAZAROTENE 0.1 g in 100 g Product Characteristics Color white Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-2094-2 30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/07/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/07/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-2094)
